Home » Topics » BioWorld Science

BioWorld Science
RSS

NMSS grant supports Clene's development of nanocatalytic therapeutic CNM-Au8 for MS

Oct. 15, 2019

Progression-free survival improved with ivosidenib in pivotal cholangiocarcinoma trial

Oct. 15, 2019

DE Shaw Research and Relay Therapeutics disclose PTPN11 inhibitors

Oct. 15, 2019

Intra-Cellular Therapies discovers 5-HT2A antagonists/mu-opioid receptor partial agonists

Oct. 15, 2019

Bristol-Myers Squibb identifies new TYK2 inhibitors

Oct. 15, 2019

Recombinant Clonorchis sinensis heat shock cognate protein B patented by Xuzhou Medical University

Oct. 15, 2019

Novel PSMA-targeting 177-Lu radiolabeled compounds with outstanding tumor uptake presented

Oct. 15, 2019

Wuhan Institute of Virology describes respiratory syncytial virus vaccine antigen

Oct. 15, 2019

Matinas BioPharma initiates EnACT study of MAT-2203 for fungal cryptococcal meningitis

Oct. 15, 2019

Patient enrollment under way in phase I study of FT-516

Oct. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...